Campbell & CO Investment Adviser LLC

Position in RPRX — Royalty Pharma plc

CIK 1353570 BALTIMORE, MD

Position in RPRX

as of Jun 30, 2026 · filed Aug 3, 2026 Compact

Position Value

$2,954,216

+$1,457,457 QoQ

Shares Held

52,688

+68.9% QoQ

Ownership

0.009%

of shares outstanding

% of Portfolio

0.16%

of 13F equity value

Holder Rank

#246

of 641 holders

Holding Since

Jun 2023

10 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Campbell & CO Investment Adviser LLC holds $72,173,828 across 47 Biotechnology names. RPRX ranks #8 (4.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	9,899	$6,172,422
2	CRSP	CRISPR Therapeutics AG	107,529	$5,864,631
3	CYTK	Cytokinetics Inc	65,978	$5,620,665
4	INSM	INSMED Inc	43,856	$4,675,926
5	IONS	Ionis Pharmaceuticals Inc	49,632	$3,935,321
6	HALO	Halozyme Therapeutics, Inc.	44,702	$3,498,825
7	ALNY	Alnylam Pharmaceuticals, Inc.	11,183	$3,366,418
8	RPRX	Royalty Pharma plc This page	52,688	$2,954,216

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,954,216	52,688	+68.9%	Shares	Sole	2026-08-03
2026-03-31	$1,496,759	31,202	-60.9%	Shares	Sole	2026-05-15
2025-12-31	$3,082,969	79,787	+56.8%	Shares	Sole	2026-02-12
2025-03-31	$1,584,517	50,900	-46.5%	Shares	Sole	2025-05-14
2024-12-31	$2,429,062	95,220	+23.3%	Shares	Sole	2025-02-10
2024-09-30	$2,184,384	77,214	+25.8%	Shares	Sole	2024-11-12
2024-06-30	$1,619,065	61,398	+149.7%	Shares	Sole	2024-08-13
2024-03-31	$746,828	24,591	+91.1%	Shares	Sole	2024-05-10
2023-12-31	$361,377	12,865	+29.0%	Shares	Sole	2024-02-13
2023-06-30	$306,477	9,970	—	Shares	Sole	2023-08-11
No filing history on record for this holder in this stock.